2025 annual financial data
Aktis Oncology 2025 Operating margin
Direct answer
Operating margin was -1,149.52%.
Operating income was -74,684,000 USD and net income was -63,731,000 USD.
Operating cash flow was -64,127,000 USD.
Get free Aktis Oncology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 6,497,000 USD
- Operating income
- -74,684,000 USD
- Net income
- -63,731,000 USD
- Operating cash flow
- -64,127,000 USD